Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
View ORCID ProfileMaría Elvira Balcells, View ORCID ProfileLuis Rojas, View ORCID ProfileNicole Le Corre, View ORCID ProfileConstanza Martínez-Valdebenito, View ORCID ProfileMaría Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Álvaro Huete, View ORCID ProfileRicardo Castro, View ORCID ProfileMauricio Sarmiento, Luis Villarroel, Alejandra Pizarro, View ORCID ProfilePatricio Ross, View ORCID ProfileJaime Santander, Barbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, View ORCID ProfileRicardo Soto-Rifo, View ORCID ProfileFernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, View ORCID ProfileCarlos Balmaceda, View ORCID ProfileManuel A. Espinoza, Jaime Pereira, Bruno Nervi
doi: https://doi.org/10.1101/2020.09.17.20196212
María Elvira Balcells
1Department of Infectious Diseases. School of Medicine. Pontificia Universidad Católica de Chile
Luis Rojas
2Department of Internal Medicine. School of Medicine. Pontificia Universidad Católica de Chile
3Program of Pharmacology and Toxicology. School of Medicine. Pontificia Universidad Católica de Chile
Nicole Le Corre
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
5Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS
Constanza Martínez-Valdebenito
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
5Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS
María Elena Ceballos
1Department of Infectious Diseases. School of Medicine. Pontificia Universidad Católica de Chile
Marcela Ferrés
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
5Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS
Mayling Chang
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
Cecilia Vizcaya
4Department of Pediatric Infectious Diseases and Immunology. School of Medicine. Pontificia Universidad Católica de Chile
Sebastián Mondaca
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
Álvaro Huete
7Department of Radiology. School of Medicine. Pontificia Universidad Católica de Chile
Ricardo Castro
8Department of Intensive Care Medicine. School of Medicine. Pontificia Universidad Católica de Chile
Mauricio Sarmiento
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
Luis Villarroel
9Department of Public Health. School of Medicine. Pontificia Universidad Católica de Chile
Alejandra Pizarro
1Department of Infectious Diseases. School of Medicine. Pontificia Universidad Católica de Chile
Patricio Ross
2Department of Internal Medicine. School of Medicine. Pontificia Universidad Católica de Chile
Jaime Santander
10Department of Psychiatry. School of Medicine. Pontificia Universidad Católica de Chile
Barbara Lara
11Emergency Medicine Section. School of Medicine. Pontificia Universidad Católica de Chile
Marcela Ferrada
12Clinical Research Center. School of Medicine. Pontificia Universidad Católica de Chile
Sergio Vargas-Salas
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
Carolina Beltrán-Pavez
13Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile. HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile
Ricardo Soto-Rifo
13Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile. HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile
Fernando Valiente-Echeverría
13Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile. HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile
Christian Caglevic
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
Mauricio Mahave
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
Carolina Selman
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
Raimundo Gazitúa
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
José Luis Briones
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
Franz Villarroel-Espindola
14Instituto Oncológico Fundación Arturo López Pérez (FALP) Santiago, Chile
15Translational Medicine Research Laboratory. Fundación Arturo López Pérez (FALP) Santiago, Chile
Carlos Balmaceda
16Health Technology Assessment Unit, Clinical Research Center, School of Medicine, Pontificia Universidad Católica de Chile
Manuel A. Espinoza
9Department of Public Health. School of Medicine. Pontificia Universidad Católica de Chile
Jaime Pereira
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
Bruno Nervi
6Department of Hematology and Oncology. School of Medicine. Pontificia Universidad Católica de Chile
Data Availability
The full data that support the findings of this study are available from the corresponding author, upon reasonable request.
Posted September 18, 2020.
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
María Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Álvaro Huete, Ricardo Castro, Mauricio Sarmiento, Luis Villarroel, Alejandra Pizarro, Patricio Ross, Jaime Santander, Barbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, Carlos Balmaceda, Manuel A. Espinoza, Jaime Pereira, Bruno Nervi
medRxiv 2020.09.17.20196212; doi: https://doi.org/10.1101/2020.09.17.20196212
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
María Elvira Balcells, Luis Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Álvaro Huete, Ricardo Castro, Mauricio Sarmiento, Luis Villarroel, Alejandra Pizarro, Patricio Ross, Jaime Santander, Barbara Lara, Marcela Ferrada, Sergio Vargas-Salas, Carolina Beltrán-Pavez, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Christian Caglevic, Mauricio Mahave, Carolina Selman, Raimundo Gazitúa, José Luis Briones, Franz Villarroel-Espindola, Carlos Balmaceda, Manuel A. Espinoza, Jaime Pereira, Bruno Nervi
medRxiv 2020.09.17.20196212; doi: https://doi.org/10.1101/2020.09.17.20196212
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)